Downloads: 222

Files in This Item:
File Description SizeFormat 
s12328-010-0198-1.pdf52.4 kBAdobe PDFView/Open
Title: Hemobilia: another complication associated with anti-thrombotic therapy
Authors: Hiramatsu, Yukiko
Watanabe, Tomohiro  KAKEN_id
Shiokawa, Masahiro  kyouindb  KAKEN_id
Kurita, Akira
Matsuura, Minoru  kyouindb  KAKEN_id
Uza, Norimitsu  kyouindb  KAKEN_id
Kodama, Yuzo  kyouindb  KAKEN_id
Chiba, Tsutomu  kyouindb  KAKEN_id
Author's alias: 渡邉, 智裕
Keywords: Hemobilia
Anti-thrombotic therapy
Liver abscess
Issue Date: Feb-2011
Publisher: Springer
Journal title: Clinical Journal of Gastroenterology
Volume: 4
Issue: 1
Start page: 49
End page: 51
Abstract: It is generally accepted that anti-thrombotic therapy increases the risk of gastrointestinal bleeding, and concurrent therapy with a proton-pump inhibitor is the standard treatment for patients receiving aspirin. Therefore, much attention has been paid to the prevention of gastrointestinal bleeding in such patients; however, it should be noted that patients on anti-thrombotic therapy always carry a risk of hemorrhage from any organ, including the gastrointestinal tract. Here, we present a case with formation of a common bile duct stone caused by hemobilia associated with anti-thrombotic therapy. This case suggests that we need to be aware of the possibility of intrabiliary hemorrhage as well as gastrointestinal bleeding in patients receiving anti-thrombotic therapy. Patients with such complications show a variety of symptoms including liver abscess, cholangitis, pancreatitis, and duodenal bleeding.
Rights: The final publication is available at www.springerlink.com
この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。This is not the published version. Please cite only the published version.
URI: http://hdl.handle.net/2433/139611
DOI(Published Version): 10.1007/s12328-010-0198-1
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.